GB2041407A - Fractionation of immunoglobulin containing solutions, such as blood plasma, by continuous flow electrophoresis - Google Patents
Fractionation of immunoglobulin containing solutions, such as blood plasma, by continuous flow electrophoresis Download PDFInfo
- Publication number
- GB2041407A GB2041407A GB8001292A GB8001292A GB2041407A GB 2041407 A GB2041407 A GB 2041407A GB 8001292 A GB8001292 A GB 8001292A GB 8001292 A GB8001292 A GB 8001292A GB 2041407 A GB2041407 A GB 2041407A
- Authority
- GB
- United Kingdom
- Prior art keywords
- solution
- immunoglobulin
- components
- aqueous solution
- migrant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
The solutions are fractionated at a pH of between 7 and 8.4 and an electrical conductivity of between 1 and 2 mScm<-1>, thereby giving rise to fractions containing particular combinations of immunoglobulin components (IgG, IgM, IgA, IgD and IgE) with potentially valuable properties. Hitherto, such solutions have been fractionated by ethanol precipitation methods (e.g. the Cohn Method). Such methods separate the IgG component of immunoglobulins but cannot separate the useful IgM component.
Description
SPECIFICATION
Fractionation of proteins
This invention relates to the fractionation of immunoglobulin containing solutions, such as blood plasma, by continuous flow electrophoresis.
The immunoglobulins constitute a family of complex proteins contained, for example, in blood plasma. They may be made up of several constituents each of which has different properties from the others in some respect or other. There are five main components found in immunoglobulins and these are usually designated as IgM, IgA, IgG, IgD and IgE respectively,
Certain of the components may be separated by techniques known in the art such as an ethanol precipitation method known as the Cohn Method which separates the IgG component, but which cannot separate the IgM component which has antibacterial antibodies lacking in the IgG component.
We have now established conditions under which immunoglobulins may be fractionated by means of continuous flow electrophoresis and surprisingly found that certain of the fractions so obtained may be constituted by mixtures of certain components having particularly advantageous properties.
The present invention provides a method of fractionating an immunoglobulin containing aqueous solution which comprises the steps of
(i) adjusting the pH of the aqueous solution to between 7 and 8.4 and the electrical conductivity thereof to between 1 and 2 mScm 1 as measured at 20"C;; (ii) subjecting the product of step (i) to continuous flow electrophoresis by injecting it as a migrant solution into a second aqueous solution, laminarly flowing in an annular separation chamber as a carrier solution for the migrant solution and stabilised by means of an angular velocity gradient, said carrier solution having a pH of between 7 and 8.4 and by applying a constant electric field across the resulting mixture to produce differential movement of the components of the immunoglobulin relative to themselves and to any other major components of the solution perpendicular to the direction of flow of the carrier solution; and
(iii) collecting resulting particular fractions containing one or more components of the immunoglobulin.
The fractions may then, if desired, be concentrated erg., by hollow fibre membrane concentrators, and then freeze dried. The fractions may be reconstituted in a small volume of liquid. Analysis of such reconstituted fractions for IgG, IgM, IgA, IgD and IgE components has shown that particular fractions may contain particular relative proportions of such components, which particular fractions may posses specific value for immunisation against specific infections.
Further details are contained in the example of this specification.
Step. (ii) is most conveniently carried out as generally described in U.K. Patent Specification
No. 1 186 184 (corresponding to U.S. Patent No. 3 616 453), which describes a process and apparatus where stabilisation of flowing streams in continuous flow electrophoresis is effected by an angular velocity gradient. Thus, in our invention, the fractionation may be effected in an annular separation chamber defined between a central stationary cylinder (a stator) and an outer rotating cylinder (a rotor), which results in a gradient of angular velocity across the annular chamber giving laminar flow at high throughputs. The constant electric field is then applied across the annular chamber to produce the differential movement of the immunoglobulin components of the migrant solution. Improvements and/or modifications of the apparatus described in U.K.Patent Specification No.1 186 184 are described in U.K. Patent Specificarion
Nos. 1 431 887 and 1 431 888 (corresponding to U.S. Patent No. 3 884 926).
The pH of the migrant and carrier solutions in step (ii) is, as stated, between 7 and 8.4; very effective fractionation is found to occur in this range, which also enables factor VIII, and for albumin, if present, to be fractionated at the same time, e.g., where the aqueous solution comprises blood plasma. Separation of factor VIII by continuous flow electrophoresis is described in the specification of our International Patent Application No.PCT/GB78/00038, filed 10th November 1 978 (Agents' Reference 11 925 M 1 H) which describes inter alia a method of purifying a factor VIII containing aqueous solution characterised by the steps of
(i) reducing the ionic strength of the solution to a level such that it is capable of being electrophoresed;
(ii) adjusting the pH of the solution to within a range where the stability of Factor VIII is not adversely affected;;
(iii) subjecting the product of step (ii) to continuous flow electrophoresis by injecting the solution as a migrant solution into a second aqueous solution, laminarly flowing in an annular separation chamber as a carrier solution for the migrant solution and stabilised by means of an angular velocity gradient, and applying a constant electric field across the resulting mixture to produce a differential movement of the factor VIII component of the migrant solution with respect to the other major components if the solution perpendicular to the direction of flow of the layer; and
(iv) collecting the separated Factor VIII component.
It is surprising that our invention operates so satisfactorily when the migrant solution has a pH of 7.5. Thus, the isoelectric point of immunoglobulins are high (between about pH 7.5 and 8.5) and under conditions of electrophoresis at pH 7.5, it might be expected that the immunoglobulins would not exhibit any movement of that they might move into the membrane in the apparatus described in U.K. Patent Specifications Nos. 1 431 887 and 1 431 888. This, however, does not happen in our experience.
A suitable buffer for the migrant solution is triscitrate and we prefer that its electrical conductivity is in the range of 0.75 to 1 mScm-1 as measured at 20"C.
Step (iii) may be carried out as described in U.K. Patent Specification Nos. 1 431 887 and 1 431 888. Thus, if our method is carried out as described in these specifications, the direction of migration of the migrant solution is centrifugal and the injection thereof accordingly effected at the inner side of the flow of the carrier solution. The direction of flow is generally upward and is helical in pattern because of the effect of the rotation of the rotor. Particular fractions may then be collected by means of an off-take system located in the stator and consisting of a series of parallel mazeplates with spacers. A particular fraction may then pass through one or more particular mazeplates and hence into collecting tube(s).
The invention will now be particularly described, by way of example only, as follows.
Example
Outdated frozen human blood plasma (250 ml) was thawed rapidly and dialysed overnight against an aqueous tris-citrate solution (10L; pH 7.5; conductivity 1 mScm- 1) at 4"C in order to reduce the salt concentration of the plasma. The dialysed plasma was then diluted approximately 1.5 times with an aqueous tris-citrate solution to give a product of pH 7.5 and an electrical conductivity of 1.0 mScm- at 20"C.
The above product, as a migrant solution, was then warmed to 20"C and electrophoresed using a continuous electrophoretic separation apparatus of the type generally described in U.K.
Patent Specification Nos. 1 431 887 and 1 431 888. The apparatus had 29 outlet ports, a stator radius of 40 mm, a rotor radius of 45 mm to give an annular gap of 5 mm, and electrodes 304 mm in length. A carrier solution at 2"C comprising an aqueous tris-citrate solution (pH 7.5; electrical conductivity 0.75 mScm-1 at 20"C) was passed upwardly through the annular gap at a rate of 500 ml/minute and the flow stabilised by rotation of the rotor. The migrant solution was injected into the annular gap at a rate of 10 ml/minute. The electrophoresis was carried out at 35 amps and 27 volts giving a temperature rise of carrier solution of 20"C. i.e., from 2"C to 22"C. The electrolytes were ammonium acetate (ism; pH 7.5) for the cathode and an equal volume mixture (pH 7.5) of ammonium citrate (0.2 M) and ammonium phosphate (0.15 M) for the anode.
The particular fractions were each collected and concentrated by hollow fibre membrane concentrators and then freeze dried. Each fraction was re-constituted in a small volume of distilled water and analysed for the immunoglobulin components IgG, IgM, IgA, lgD and IgE by quantitative iinmunoelectrophoresis. The results are shown in Table I below as percentage of activity per minute per off-take.
TABLE 1
Fraction IgG IgM IgA lgD IgE
No
1 0.9 0.1
2 3.1 0.3
3 7.4 0.6 0.2
4 8.6 1.9 0.4
5 6.5 4.0 0.4 0.6
6 6.8 5.7 0.1 1.2 0.5
7 6.8 5.9 0.2 1.7 0.8
8 10.1 9.0 0.7 5.2 1.4
9 14.1 17.5 3.4 15.6 5.2
10 10.0 16.1 6.6 20.3 7.8 11 9.6 16.4 15.0 23.4 20.2 12 6.7 9.0 17.9 12.7 24.0
13 4.5 6.4 20.0 10.8 15.6 14 3.2 4.5 21.1 5.8 15.0 15 1.9 2.7 15.0 2.8 8.5
It will be seen that, apart from IgG which shows a broad spread across about 1 5 fraction numbers, the bulk of the remaining immunoglobulin components are present in about six fraction numbers, specifically 8 to 1 3. Also, it will be noted that at the pH of this example (7.5) the mobilities of the immunoglobulin components are sufficiently different for fractions to be collected in order to maximise the proportion of any one particular component.The order of decreasing mobility is IgA, IgE, lgD, IgM and IgG. Table II shows how fractions may be combined in order to obtain mixtures of immunoglobulin components of various composition.
TABLE II
Fractions Immunoglobulin Total
Numbers
Combined 1-7 IgG 40
IgM 20
IgG 45
IgM 60 8-11 IgA 25 lgD 65
IgE 35
IgG 15
IgM 20 12-15 IgA 75 lgD 35
IgE 65
Certain of the fractions obtained were combined and analysed for specific antibodies, namely anti-tetanus, anti-measles, anti-rubella and anti-polio virus type Ill. The techniques used for analysis were radial immuno-diffusion for anti-tetanus antibodies, haemaglutination inhibition tests for anti-measles and anti-rubella antibodies, and tissue culture neutralisation tests for antipolio virus type Ill antibodies. The results are shown in Table III below.
TABLE 111
Fractions Specific Antibodies (% /fraction) Numbers (combined) Tetanus Measles Rubella Polio virus
Type III
1, 2 17.7 16.6 17.5 22.6 3, 4 31.5 44.2 51.1 -30.2
5, 6 23.5 17.4 20.2 16.9 7,8 13.8 12.5 7.2 12-.3
9, 10 9.4 5.0 2.9 9.7
11, 12 4.1 4.4 1.2 8.4
It will be seen that the anti-bodies are principally contained in the early fractions up to fraction 6, These early fractions contain mainly the IgG and IgM components (see Table I). Thus, by combining specific fractions in a pool, high specific activity anti-body preparations can be prepared simply, leaving the other fractions for other uses. Also, IgM, which is a large molecular weight immunoglobulin, tends to possess good antibacterial properties and fractions containing it might be used in treatment where the prime aim is to obtain immunity against certain bacterial infections.
It should be noted that the fractions obtained were not necessarily pure. Thus, from fraction numbers 8 to 10 and higher, other plasma proteins were present including fibrinogen which may be removed by other means. This though is probably not of great practical importance.
However, albumin, the major plasma protein, was well sepatated and all of the fractions were albumin free.
Claims (8)
1. A method of fractionating an immunoglobulin-containing aqueous solution which comprises the steps of
(i) adjusting the pH of the aqueous solution to between 7 and 8.4 and the electrical conductivity thereof to between 1 and 2 mScm-1 as measured at 20"C; (ii) subjecting the product of step (i) to continuous flow electrophoresis by injecting it as a migrant solution into a second aqueous solution, laminarly flowing in an annular separation chamber as a carrier solution for the migrant solution and stabilised by means of an angular velocity gradient said carrier solution having a pH of between 7 and 8.4, and by applying a constant electric field across the resulting mixture to produce differential movement of the components of the immunoglobulin relative to themselves and to any other major components of the solution perpendicular to the direction of flow of the carrier solution; and
(iii) collecting resulting particular fractions containing one or more components of the immunoglobulin.
2. A method according to claim 1 wherein, in step (i), the pH of the aqueous solution is adjusted to 7.5 and the electrical conductivity thereof to 1 mScm-1 as measured at 20"C.
3. A method according to either of the preceding claims wherein the migrant solution has an electrical conductivity in the range of 0.75 to 1 mScm-1 as measured at 20"C.
4. A method according to any of the preceding claims wherein the resulting fractions are concentrated.
5. A method according to any of the preceding claims wherein the immunoglobulincontaining aqueous solution comprises blood plasma.
6. A method according to claim 5 wherein factor VIII and/or albumin are fractionated at the same time as the particular fractions containing one or more components of the immunoglobulin.
7. A method of fractionating an immunoglobulin-containing aqueous solution substantially as described herein with reference to the example.
8. A fraction containing one or more components of immunoglobulin when prepared by a method according to any one of the preceding claims.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8001292A GB2041407B (en) | 1979-02-16 | 1980-01-15 | Fractionation of immunoglobulin containing solutions such as blood plasma by continuous flow electrophoresis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7905600 | 1979-02-16 | ||
GB8001292A GB2041407B (en) | 1979-02-16 | 1980-01-15 | Fractionation of immunoglobulin containing solutions such as blood plasma by continuous flow electrophoresis |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2041407A true GB2041407A (en) | 1980-09-10 |
GB2041407B GB2041407B (en) | 1983-04-13 |
Family
ID=26270600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8001292A Expired GB2041407B (en) | 1979-02-16 | 1980-01-15 | Fractionation of immunoglobulin containing solutions such as blood plasma by continuous flow electrophoresis |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2041407B (en) |
-
1980
- 1980-01-15 GB GB8001292A patent/GB2041407B/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB2041407B (en) | 1983-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kelly et al. | Biochemical and physiological properties of a purified snake venom neurotoxin which acts presynaptically | |
Van Mourik et al. | Factor VIII, a series of homologous oligomers and a complex of two proteins | |
Nichol et al. | Biophysical Studies of Blood Plasma Proteins. VII. Separation of γ-Globulin from the Sera of Various Animals1 | |
Volanakis et al. | Rabbit C1q: purification, functional and structural studies | |
Bhakdi et al. | Isolation of the terminal complement complex from target sheep erythrocyte membranes | |
Williams Jr et al. | Immunoelectrophoretic Studies on Serum Proteins: III. Human Gamma Globulin | |
US4246085A (en) | Fractionation of proteins | |
WO2002036245A1 (en) | Integrated separation methods | |
US4250008A (en) | Purification of Factor VIII | |
GB2041407A (en) | Fractionation of immunoglobulin containing solutions, such as blood plasma, by continuous flow electrophoresis | |
CA1108535A (en) | Protein and process for isolating it | |
Josephson et al. | Gel isoelectric focusing of selected bovine immunoglobulins | |
Murgita et al. | Isoelectric separation of mouse immunoglobulins | |
CA1170618A (en) | Blood fractionation improvement | |
Baldo | Natural'erythrocyte agglutinins in the serum of the Australian freshwater catfish, Tandanus tandanus Mitchell: II. Serum fractionation studies | |
US3475402A (en) | Process of extracting proteins from mistle press juice by carrier-free electrophoresis | |
EP1980570A2 (en) | Purification of Antibodies | |
Tanner | Immunochemical study of the antigens of Trichinella spiralis larvae. II. Some physicochemical properties of these antigens | |
US20020028917A1 (en) | Separation of avian antibodies | |
US20040242849A1 (en) | Purification of antibodies | |
Inman et al. | The association of J chain with the Fc region of human IgM | |
Watanabe et al. | Microheterogeneity of rat al-fetoprotein and immunochemical properties | |
Romero-Piffiguer et al. | A simple two-step method for purification of secretory IgA from human colostrum | |
Shukun et al. | Concentration of proteins in the free‐flow electrophoretic apparatus | |
Bendtzen | Partial purification of human leucocyte migration inhibitory factor (LIF) by immunosorption of supernatant protein contaminants detected by crossed immunoelectrophoresis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |